| Swainsonine | IC50 | 10.0 [1], 50.0 [2], 20000.0 [3] |
| (2R,3R,4S)-2-({[(1R)-2-Hydroxy-1-phenylethyl]amino}methyl)pyrrolidine-3,4-diol | IC50 | 50000.0 [1] |
| (2R,3R,4S)-2-({[(1R)-2-Hydroxy-1-phenylethyl]amino}methyl)pyrrolidine-3,4-diol | Ki | 23300.0 [1] |
| [(2R)-2-[[(2R,3R,4S)-3,4-Dihydroxypyrrolidin-2-yl]methylamino]-2-phenylethyl] 4-bromobenzoate | IC50 | 75000.0 [1], 200000.0 [2] |
| (3r,4r,5r)-3,4-Dihydroxy-5-({[(1r)-2-Hydroxy-1-Phenylethyl]amino}methyl)pyrrolidin-2-One | IC50 | 50000.0 [1], 75000.0 [2], 350000.0 [3] |
| (3r,4r,5r)-3,4-Dihydroxy-5-({[(1r)-2-Hydroxy-1-Phenylethyl]amino}methyl)-1-Methylpyrrolidin-2-One | Ki | 550.0 [1], 670.0 [2], 3200.0 [3] |
| [(2R)-2-[[(2R,3R,4R)-3,4-Dihydroxy-1-methyl-5-oxopyrrolidin-2-yl]methylamino]-2-phenylethyl] 4-bromobenzoate | IC50 | 750.0 [1], 7500.0 [2], 75000.0 [3] |
| [(2R)-2-[[(2R,3R,4R)-3,4-Dihydroxy-5-oxopyrrolidin-2-yl]methylamino]-2-phenylethyl] 4-bromobenzoate | IC50 | 75000.0 [1], 150000.0 [2], 750000.0 [3] |
| Miglitol | IC50 | 379000.0 [1] |
| (3S,5R)-4-(2-Hydroxyethyl)piperidine-3,4,5-triol | IC50 | 1826000.0 [1] |
| (3S,5R)-1-Butyl-4-(2-hydroxyethyl)piperidine-3,4,5-triol | IC50 | 252000.0 [1] |
| (3R,5S)-1-Hexyl-4-(2-hydroxyethyl)piperidine-3,4,5-triol | IC50 | 183000.0 [1] |
| (3R,5S)-4-(2-Hydroxyethyl)-1-octylpiperidine-3,4,5-triol | IC50 | 143000.0 [1] |
| (3S,5R)-1-Decyl-4-(2-hydroxyethyl)piperidine-3,4,5-triol | IC50 | 112000.0 [1] |
| (3S,5R)-1,4-Bis(2-hydroxyethyl)piperidine-3,4,5-triol | IC50 | 873000.0 [1] |
| 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2S,3S,4R,5R)- | IC50 | 64000.0 [1] |